Article ID Journal Published Year Pages File Type
10514218 Journal of Clinical Epidemiology 2013 11 Pages PDF
Abstract
The unanticipated finding of a positive average true effect and superiority of the new treatment in most NI trials suggest that the current practice of choosing NI designs in clinical trials makes degradation on average unlikely. However, the distribution of true treatment effects demonstrates that, in some NI trials, the new treatment is distinctly inferior.
Related Topics
Health Sciences Medicine and Dentistry Public Health and Health Policy
Authors
, ,